Biomarin Pharmaceutical PE ratio BMRN

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Oct 23, 2026: 151×
6-year median: 70.6×
Against its 6-year history: 69th; percentile: 0 is its lowest day, 100 its highest
6-year range: 15.6× to 495×
Peer median: 60.3×

Biomarin Pharmaceutical's PE ratio is 151× as of Oct 23, 2026: a share price of $55.95 against $0.37 of earnings per share over the last twelve months.

That is above its 6-year median of 70.6×, higher than on 69% of days in the last 6 years.

Over that time it ranged from 15.6× in Oct 2025 to 495× in Jul 2022.

The median for 10 large drugmakers of a similar size is 60.3×.

PE ratio over time

median 70.6×

The dashed line is the 6-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	151×	20.6×	182×
2025	22.6×	15.6×	40.9×
2024	40.1×	38.0×	125×
2023	125×	103×	279×
2022	246×	196×	495×
2021	17.2×	17.1×	21.1×
2020	20.1×	17.4×	210×
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	n/m a value too high to mean anything
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	n/m a value too high to mean anything
2013	n/m a value too high to mean anything
2012	n/m a value too high to mean anything
2011	23.9×	16.7×	23.9×

Against its peers

Companies in Drug Manufacturers - General nearest Biomarin Pharmaceutical's size, closest first, today.

Company	PE ratio
BMRNBiomarin Pharmaceutical	151×
CORTCorcept Therapeutics	204×
PTGXProtagonist Therapeutics	134×
JAZZJazz Pharmaceuticals	14.6×
TGTXTG Therapeutics	19.8×
ALKSAlkermes plc.	115×
AMRXAmneal Pharmaceuticals	41.6×
LGNDLigand Pharmaceuticals	32.3×
KNSAKiniksa Pharmaceuticals International	79.1×
INDVIndivior Pharmaceuticals	12.4×
ARQTArcutis Biotherapeutics	142×
Peer median	60.3×

Where Biomarin Pharmaceutical ranks

#40of 41Large drugmakers with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Biomarin Pharmaceutical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.